201 related articles for article (PubMed ID: 35081861)
1. COVID-19 in Southeast Asia: current status and perspectives.
Chu DT; Vu Ngoc SM; Vu Thi H; Nguyen Thi YV; Ho TT; Hoang VT; Singh V; Al-Tawfiq JA
Bioengineered; 2022 Feb; 13(2):3797-3809. PubMed ID: 35081861
[TBL] [Abstract][Full Text] [Related]
2. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
Bui NN; Lin YT; Huang SH; Lin CW
Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
[TBL] [Abstract][Full Text] [Related]
3. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
[TBL] [Abstract][Full Text] [Related]
4. Status of COVID-19 vaccination around South Asia.
Hayat M; Uzair M; Ali Syed R; Arshad M; Bashir S
Hum Vaccin Immunother; 2022 Dec; 18(1):2016010. PubMed ID: 35061956
[TBL] [Abstract][Full Text] [Related]
5. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
7. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.
Li Q; Wang J; Tang Y; Lu H
Drug Discov Ther; 2021; 15(3):118-123. PubMed ID: 34234059
[TBL] [Abstract][Full Text] [Related]
8. Genomic Surveillance of SARS-CoV-2 Variants That Emerged in South and Southeast Asia during Early 2022.
Yu Q; Tong X; Zuo L; Tao X; Xu Z; Li X; Liu H; Guan W; Liu D; Liu H; Huang F; Jia L
Viruses; 2023 Jun; 15(6):. PubMed ID: 37376654
[TBL] [Abstract][Full Text] [Related]
9. Multistate Outbreak of SARS-CoV-2 B.1.1.529 (Omicron) Variant Infections Among Persons in a Social Network Attending a Convention - New York City, November 18-December 20, 2021.
Smith-Jeffcoat SE; Pomeroy MA; Sleweon S; Sami S; Ricaldi JN; Gebru Y; Walker B; Brady S; Christenberry M; Bart S; Vostok J; Meyer S; Seys S; Markelz A; Ditto N; Newbern V; Thomas FJ; Thomas D; Cabredo E; Kellner S; Brown VR; Tate JE; Kirking HL
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):238-242. PubMed ID: 35176004
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History.
Drews SJ; Hu Q; Samson R; Abe KT; Rathod B; Colwill K; Gingras AC; Yi QL; O'Brien SF
Microbiol Spectr; 2022 Feb; 10(1):e0226221. PubMed ID: 35171006
[TBL] [Abstract][Full Text] [Related]
11. Omicron variant as nature's solution to the COVID-19 pandemic.
Li Wan Po A
J Clin Pharm Ther; 2022 Jan; 47(1):3-5. PubMed ID: 35128705
[TBL] [Abstract][Full Text] [Related]
12. An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward.
Wi YM; Kim SH; Peck KR
J Korean Med Sci; 2022 Jan; 37(4):e28. PubMed ID: 35075827
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2, Covid-19, and the debunking of conspiracy theories.
Hakim MS
Rev Med Virol; 2021 Nov; 31(6):e2222. PubMed ID: 33586302
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.
Zhang M; Liang Y; Yu D; Du B; Cheng W; Li L; Yu Z; Luo S; Zhang Y; Wang H; Zhang X; Zhang W
Int J Biol Sci; 2022; 18(2):889-900. PubMed ID: 35002532
[TBL] [Abstract][Full Text] [Related]
18. Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern.
Xie T; Lu S; He Z; Liu H; Wang J; Tang C; Yang T; Yu W; Li H; Yang Y; Yang H; Yue L; Zhou Y; Yang F; Luo Z; Li Y; Xiang H; Zhao Y; Wang J; Wang H; Long R; Kuang D; Tan W; Peng X; Li Q; Xie Z
Signal Transduct Target Ther; 2022 Feb; 7(1):61. PubMed ID: 35217639
[TBL] [Abstract][Full Text] [Related]
19. Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants.
Choi A; Koch M; Wu K; Dixon G; Oestreicher J; Legault H; Stewart-Jones GBE; Colpitts T; Pajon R; Bennett H; Carfi A; Edwards DK
J Virol; 2021 Nov; 95(23):e0131321. PubMed ID: 34549975
[TBL] [Abstract][Full Text] [Related]
20. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
